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Accurate control of the cell redox state is mandatory for maintaining the structural integrity and physiological functions. This
control is achieved both by a fine-tuned balance between prooxidant and anti-oxidant molecules and by spatial and temporal
confinement of the oxidative species. The diverse cellular compartments each, although structurally and functionally related,
actively maintain their own redox balance, which is necessary to fulfill specialized tasks. Many fundamental cellular processes such
as insulin signaling, cell proliferation and differentiation and cell migration and adhesion, rely on localized changes in the redox
state of signal transducers, which is mainly mediated by hydrogen peroxide (H
2
O
2
). Therefore, oxidative stress can also occur long
before direct structural damage to cellular components, by disruption of the redox circuits that regulate the cellular organelles
homeostasis. The hepatocyte is a systemic hub integrating the whole body metabolic demand, iron homeostasis and detoxification
processes, all of which are redox-regulated processes. Imbalance of the hepatocyte’s organelles redox homeostasis underlies virtually
any liver disease and is a field of intense research activity. This review recapitulates the evolving concept of oxidative stress in the
diverse cellular compartments, highlighting the principle mechanisms of oxidative stress occurring in the healthy and wounded
hepatocyte.
1. Introduction
1.1. RedoxHomeostasis andOxidative Stress. Accurate control
of the cell redox state, which is mandatory for maintain-
ing the structural integrity and physiological functions, is
achieved both by a fine-tuned balance between prooxidant
and anti-oxidant molecules and by spatial and temporal
confinement of the oxidative species. This tight regulation is
mainly achieved by controlling the steady-state production
and the subcellular compartmentalization of reactive oxy-
gen (ROS) and reactive nitrogen species (RNS), prooxidant
enzymes such as NADH/NAPDH oxidases (NOX) and glu-
tathione peroxidases (Gpx) and that of several antioxidant
systems such as reduced/oxidized glutathione (GSH/GSSG),
reduced/oxidized cysteine (Cys/CySS), thioredoxin (Trx),
peroxiredoxin (Prx), superoxide dismutase (SOD), and cata-
lase.
While it has long been recognized that an imbalance
between pro- and anti-oxidants is harmful to cells and is
a central mechanism in the development of several patholo-
gies including neurodegeneration, atherosclerosis, diabetes,
cancer, and aging, the importance of ROS as second mes-
sengers in the cell physiology is a relatively recent acquisi-
tion. Indeed, many fundamental cellular processes such as
insulin signaling, cell proliferation and differentiation, and
cell migration and adhesion, just to name a few, rely on
localized changes in the redox state of signal transducers
mainly mediated by hydrogen peroxide (H
2
O
2
) [1].
The widespread notion of oxidative stress is that an
excessive production of prooxidants or exhaustion of the
cellular anti-oxidant defenses can lead to oxidative damage
to proteins, nucleic acids, carbohydrates, and lipids, in which
radical ROS or RNS are generally thought to play a major
role. However, since the activities of many proteins involved
in the cellular signaling are regulated by the redox state of
their oxidizable thiol residues, which act as redox-sensitive
molecular-switches [2], oxidative stress can also occur in
the absence of direct structural damage by disruption of
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Figure 1: Sites of physiologically produced ROS. Plasma membrane localized ROS bursts deactivate PTPs and allow signal transduction
(i.e., by insulin or IGF-1) after tyrosine kinase receptor activation. Mitochondria produce ROS during cellular respiration and metabolic
activity. ROS are produced in the ER during protein folding and detoxification by the cytochrome P450 systems. Lysosomes are required
for iron metabolism and the removal of damaged cellular components through autophagy. Peroxisomes produce ROS during metabolic or
detoxification activities.
the redox circuits that regulate many signaling pathways
[3]. Among ROS, hydrogen peroxide is supposed to play
a major role either directly or indirectly, in the regulation
of the thiol/disulphide redox switches [4], because (i) these
reactions typically require a two-electron transfer, (ii) H
2
O
2
is kinetically restricted and thus can be highly selective in sub-
strate oxidation, and (iii) H
2
O
2
is generated following growth
factor, cytokine, or hormone signaling. However, the detailed
molecular mechanisms leading to selective thiol oxidation in
redox-sensitive proteins by H
2
O
2
are still mostly obscure and
are the focus of intense research activity. A growing body
of data suggests that altered redox signaling precedes and
contributes substantially more than direct radical damage to
the development of several human pathologies.
The concept of “oxidative stress,” introduced 30 years ago
[5], evolved over time from the original oxidative damage to
the cell structure and subsequent stress response to include
that of alteration of signaling pathways, redox homeostasis,
and redox adaptation to stress [6, 7].
Consequently, oxidative stress is not necessarily harmful
and antioxidants are not utterly beneficial. In fact, many
clinical trials failed to prove the efficacy of low-molecular
weight antioxidants in the treatment of several pathologies,
and the use of the antioxidants selenium, beta-carotene, and
vitamin E was even found to increase overall mortality in a
large meta-analysis [8].
Our understanding of the redox landscape of the cell is
rapidly evolving and thanks to the recent development of
specific redox probes [9–12] we are beginning to unravel
a complex spatial and temporal organization of the redox
fluxes in the living cells. Compartmentalization of the redox
circuitry is crucial to maintain physiology and is a key to
understand the alterations of the redox homeostasis occur-
ring in disease.
The liver is the main metabolic organ and plays a funda-
mental role in whole body detoxification and blood stream
filtering. Most detoxification processes (drugs, alcohol, and
endo- and xenobiotics) are carried out through oxidative
reactions by the cytochrome P450 (CYP) isoenzymes, which
generate superoxide anion (O
2
∙−) (Figure 1). Derangement
of the liver metabolic processes, such as those occurring
by fatty acids overload in NAFLD, results in increased
ROS production by increased electron transfer during mito-
chondrial 𝛽-oxidation, as well as increased CYP2E1 expres-
sion and activity [13]. Strong induction of CYP2E1 also
occurs due to excessive consumption of ethanol, whose toxic
metabolite acetaldehyde (AcCHO) generates oxidative stress
through a number of direct and indirect mechanisms [6, 14,
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Figure 2:Mechanisms of enhanced ROS production during hepatocyte damage. Ethanolmetabolism promotes strong ROS production in the
ER by the inducible CYP. It impairs GSH import in the mitochondria, preventing ROS removal. It also impairs 𝛽-oxidation promoting lipid
accumulation. ETOH induces lipid-raft clustering and increases iron uptake, promoting Fe2+ leakage from lysosomes and increased Fe2+ loads
in mitochondria and ER, resulting in ROS production. Ethanol also reduced the autophagic removal of damaged cellular components. Viral
infection challenges the ER protein folding process leading to ROS production and Ca2+ leakage in the cytosol and mitochondria. Increased
MAMs formation promotes Ca2+ efflux from ER into mitochondria, increasing mitochondrial ROS production.
15] (Figure 2). Hepatotropic viruses cause direct oxidative
damage to the endoplasmic reticulum (ER) of hepatocytes,
triggering an inflammatory response which propagates the
oxidative stress-induced damage to neighboring cells. Acti-
vation of the inflammatory signaling pathways in the hepa-
tocyte (i.e., due to translocation of bacterial toxins from the
gut or inflammatory cytokines release from visceral fat in
obese subjects) is a trait d’union molecular mechanism that
synergistically propagates the oxidative stress within different
cellular compartments, regardless of the initiating agent.
The liver also plays a central role in heme catabolism
and iron recycling, which poses an additional threat since
iron catalyzes the formation of ROS through the Fenton and
Haber-Weiss reactions (see Section 1.2). Iron accumulation
in the liver is associated with increased oxidative stress
and can occur as a consequence of genetic disorders (as
in hemochromatosis) but also secondarily to other liver
diseases, such as NAFLD [16–18] or HCV infection [19, 20],
significantly contributing to the progression of disease.
Therefore, the liver has an enormous potential for the
generation of oxidative species, and virtually any noxia
targeting the liver results in elevated oxidative stress that,
when chronic, promotes the fibroproliferative response and
progression through fibrosis, cirrhosis, and eventually hepa-
tocellular carcinoma. The onset and progression of chronic
liver disease require a complex interplay among different
cellular components of the liver, hepatocytes, cholangiocytes,
Kupffer cells, sinusoidal endothelial cells, and hepatic stellate
cells, mostly orchestrated through a proinflammatory and
profibrogenic crosstalk in which oxidative stress mediators
such as H
2
O
2
or nitric oxide (∙NO) are active players.
As we become more and more aware of the complexity of
the redox signaling underlying crucial metabolic regulations,
cell fate decision mechanisms, and intercellular communica-
tion, it is easy to foresee that the “redox hepatology” field will
shape the liver biology research in the next future.
This review recapitulates the evolving concept of oxida-
tive stress in diverse cellular compartments, highlighting the
principle mechanisms of oxidative stress occurring in the
healthy and wounded hepatocyte.
1.2. Mechanism of Reactive Oxygen and Nitrogen Species
(RONS) Mediated Toxicity. Several ROS (O
2
∙−, ∙OH, and
H
2
O
2
) and RNS (∙NO, ONOO−) are generated inside the
cells under physiological and pathological conditions. The
biological activity of RONS toward cellular substrate is not
4 Oxidative Medicine and Cellular Longevity
equivalent: the hydroxyl radical (∙OH) has an indiscriminate
reactivity toward most biological substrates and is the most
relevant ROS involved in oxidative DNA damage while O
2
∙−,
the most abundant mitochondrial ROS, preferentially reacts
with iron-sulfur clusters in target proteins and is effectively
converted to H
2
O
2
, which is the principal oxidant of low pKa
cysteine residues (Cys) acting as sulfur switches in redox-
sensitive proteins [21].
Nitric oxide is a highly diffusible signaling molecule gen-
erated by Nitric Oxide Synthases (eNOS, iNOS, and mNOS)
in the cytoplasm, extracellular space, and possibly mitochon-
dria [22] and can react with redox-sensitive cysteine residues
in proteins forming nitrosothiols, a mechanism of redox
sensing analog to hydrogen peroxide (H
2
O
2
) [23]. ∙NO does
not appear to be toxic at physiological concentrations [24]
but can readily react with superoxide anion and generate
peroxynitrite (ONOO−), a spontaneous reaction occurring at
such a fast rate that outperforms SOD capability of removing
O
2
∙−. Peroxynitrite is therefore formed whenever ∙NO and
O
2
∙− are produced simultaneously [25]; it is highly reactive
toward iron-sulfur clusters (present in several metabolic
enzymes like mitochondrial aconitase and alcohol dehydro-
genase), can oxidize protein thiols, and promote tyrosine
nitration in target proteins (i.e., Complexes I, II, III, and
V of the mitochondrial Electron Transport Chain (ETC)),
thereby impairing both the redox- and phosphorylation-
dependent cellular signaling. A major mechanism of perox-
ynitrite toxicity is mediated by lipid peroxidation that causes
the degradation of membranes through radical reactions,
leading to changes in membrane permeability and fluidity.
Finally, oxidative damage to DNA is a hallmark of high-
level oxidative stress not only in the nuclei but also in
mitochondria [25].
Moreover, while highly reactive radical ROS and RNS
are generally diffusion-limited, some ROS and RNS can
easily diffuse through biological membranes thanks to their
non-/low-polar nature (H
2
O
2
, ∙NO, and peroxynitrous acid
ONOOH) and to dedicated transporter such as aquapor-
ins (for H
2
O
2
) or the HCO
3
−/Cl− anion exchanger (for
ONOO−). The pKa for the couple ONOO/ONOOH is 6.8,
very close to physiological pH, thus implying that both
mechanisms of peroxynitrite diffusion are relevant in vivo
[26]. Therefore, depending on the given RONS involved,
oxidative stress can elicit localized alteration of the redox
state, localized structural damage, or spread among different
cellular compartments and neighboring cells. An elucidating
mechanism of such event is the ROS-Induced ROS Release
(RIRR) [27], that is, the temporarily opening ofmitochondria
permeability transition pore (mPTP) that elicit an amplified
ROS production after an oxidative challenge. ROS released
during RIRR may spread to neighboring mitochondria and,
depending on the level of ROS release, either promote
mitophagy and removal of nonfunctional mitochondria or
trigger a ROS avalanche that can lead to cell death. Of
importance, RIRR is considered to be themainmechanism of
hepatocyte damage during ischemia/reperfusion injury that
occurs following hepatic surgery or transplantation.
Iron overload constitutes a source of oxidative stress
of particular relevance in the liver, since hepatocytes and
Kupffer cells are the main cell type devoted to iron storage
in the body. Iron is an essential component of oxygen sensing
proteins, oxygen transport systems, and iron-sulfur contain-
ing enzymes [28]; it is a transition metal readily converted
between the reduced ferrous (Fe2+) and the oxidized ferric
(Fe3+) forms. The majority of iron in biological complexes
is kept as Fe3+, while iron reduction to Fe2+ is crucial for its
mobilization and transport through membranes, loading on
ferritin and heme synthesis [28].
In the hepatocyte, iron is stored in the cytoplasm, ER,
mitochondria, and lysosomes largely as ferritin-bound Fe3+.
About 0.2%–5% of the total cellular iron is considered as
intracellular transiently mobile “labile pool,” either “free”
iron or loosely bound “chelatable” iron, both mainly in
the form of redox-active Fe2+ [29]. The “labile pool” iron
is potentially toxic, since it can catalyze the formation of
dangerous ∙OH radical through the Fenton (1) and Haber-
Weiss (3) reactions:
Fe2+ +H
2
O
2
󳨀→ Fe3+ +OH− + ∙OH (1)
Fe3+ +O
2
∙− 󳨀→ Fe2+ +O
2
(2)
The net reaction: O
2
∙− +H
2
O
2
󳨀→ OH− +O
2
+ ∙OH
(3)
Therefore, leakage of Fe2+ from the lysosome due to
altered membrane permeability, as well as reduction of Fe3+
by superoxide (2), can catalyze the production of ROS
and promote lipid peroxidation and severe cellular damage
(Figure 2). Mitochondria are particularly susceptible to iron-
mediated oxidative stress due to the high production rate
of O
2
∙− and its dismutation product H
2
O
2
during cellular
respiration in close proximity to several Fe-S containing
enzymes [30].
2. Mitochondria
Among cellular organelles, mitochondria account for the
largest amount of electron transfer to oxygen thanks to the
electron transfer chain (ETC) complexes I–V. ETC com-
plex I (NADH ubiquinone oxidoreductase) and complex
II (ubiquinone cytochrome c oxidoreductase), as well as
other mitochondrial enzymes such as 𝛼-ketoglutarate dehy-
drogenase, pyruvate phosphate dehydrogenase, fatty acyl
CoA dehydrogenase, and glycerol 3-phosphate dehydroge-
nase [31], can produce O
2
∙− as byproduct [32], releasing
it within the mitochondrial matrix. Moreover, H
2
O
2
is
produced by the monoamine oxidases (MAOs) located in
the outermitochondrialmembrane [33] (Figure 1).Therefore,
mitochondria are often referred to as amajor ROSproduction
site, although in fact whether high ROS leakage occurs
in the mitochondria, at least in a physiological setting, is
still highly debated [34, 35]. Estimates of H
2
O
2
produc-
tion, as a measure of O
2
∙− leakage, vary from 2% [36]
to 0.1-0.2% [31, 32, 34] of total O
2
consumption and vary
largely depending on tissue origin, experimental settings, and
the specific substrate fed to the mitochondria. For liver
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mitochondria, the rate of ROS leakage could be even lower
than 0.1% [32]. In fact, sincemitochondria are physiologically
prone to produce high ROS levels due to the oxidative
phosphorylation process, they are also well equipped with
a large array of antioxidant systems and radical scavengers,
such as Mn-Superoxide Dismutase (Mn-SOD), CuZn-SOD,
GSH, glutathione peroxidase, tioredoxin-2, peroxiredoxins,
glutaredoxins, and also catalase [37]. Mn-SOD (SOD2) in
themitochondrial matrix readily catalyzes the dismutation of
O
2
∙− to H
2
O
2
, which in turn is eliminated by glutathione per-
oxidase using reduced glutathione (GSH) as hydrogen donor.
Oxidized glutathione (GSSG) is then reduced by NADPH-
dependent glutathione reductase. Superoxide released in the
intermembrane space by the ETC complex III is scavenged
by CuZn-SOD (SOD1), followed again by GPx and GSH
to eliminate H
2
O
2
. Since GSH is only synthetized in the
cytosol [38] and the mitochondrial pool of GSH (mGSH) is
replenished by importing GSH produced in the cytoplasm
[39], the GSH/GSSG redox state inside the mitochondria is
heavily controlled byGSH import through the 2-oxoglutarate
carrier and the dicarboxylate carrier [40–43].
Two major enzymatic antioxidant systems collaborate in
the mitochondrial matrix: the GSH-dependent glutathione
peroxidase and the NADPH-dependent thioredoxin-2 sys-
tems, each with specific cofactors.
It must be noted that although abundant, GSH has
very limited spontaneous antioxidant activity but very high
affinity for GPx. Within the mitochondria, GPx1 [44, 45]
and Gpx4 are the most abundant with GPx1 representing
over one-third of total GPx activity in the liver [46]. Gpx1
is the major isoform localized both in the mitochondrial
matrix and in the intermembrane space and ismainly devoted
to H
2
O
2
detoxification, while GPx4 preferentially reduces
lipid peroxides thereby preventing membrane damage to
mitochondria [47].
Nevertheless, a number of molecular mechanisms pro-
mote mitochondrial ROS overproduction or decreased
antioxidant defense under nonphysiological condition [48].
The alteration of the redox homeostasis of mitochondria
is well documented in several human pathologies such as
NAFLD, viral infection, and toxic events (Figure 2).
Chronic alcohol feeding depletes the mGSH in several
animal models [49–51], leading to enhanced ROS produc-
tion and mitochondrial damage. The mechanism underlying
mGSH depletion involves cholesterol accumulation in the
inner mitochondrial membrane that results in excess mem-
brane rigidity and impaired GSH carriers functionality, thus
disrupting GSH import from the cytosol (Figure 2). In fact,
restoring the membrane fluidity, but not increasing cyto-
plasmic levels of GSH by N-acetylcysteine administration
(NAC), recovers mGSH pool and ameliorates liver damage
in alcohol-fed rats [45, 50]. The importance of GSH import
in the mitochondria can be appreciated considering that
several antioxidant systems depend upon mGSH and that
themitochondrial GSH/GSSG redox state is evenmaintained
in a more reduced steady-state redox potential than in the
cytoplasm [52], thus requiring energy expenditure for GSH
import.
The absence of protective histones, incomplete DNA
repair mechanisms, and the close proximity to ROS produc-
tion site renders mitochondrial DNA (mDNA) sensitive to
oxidative damage, increasing the risk of double-strand breaks
and somatic mutations with increased ROS production [53].
Indeed, a single dose of alcohol proved effective in inducing
massive mitochondrial DNA degradation through a ROS-
dependent pathway [54]. The acute degradation of mDNA
is then followed by an overshoot of mDNA synthesis as a
compensatory mechanism. However, repeated administra-
tion of alcohol (binge drinking) accumulated DNA damage
and blocked the adaptive response of mDNA resynthesis,
resulting in prolonged hepatic mDNA depletion [55]. mDNA
encodes 13 proteins involved in the ETC, two rRNA, and all
the tRNA necessary for translating the 13 encoded proteins.
Mutations in the mDNA therefore may produce dysfunc-
tional ETC complexes, increase ROS production, and expose
the mitochondria to new damage in a vicious circle [53].
Indeed, mitochondrial DNA depletion and mutation have
been described in patients with alcoholic and nonalcoholic
steatohepatitis [56, 57].
Acetaldehyde (AcCHO) produced by ethanolmetabolism
is readily detoxified by aldehyde dehydrogenase 1 (ALDH1)
in the cytosol and by ALDH2 in the mitochondria. Acetalde-
hyde oxidation to acetate generates NADH and reduces the
NAD+/NADH ratio, possibly impairing mitochondrial 𝛽-
oxidation which requires NAD+ (Figure 2).
Chronic alcohol administration reduces ALDH activity
therefore promoting AcCHO accumulation and inducing
adduct formation with lipids, proteins, and mDNA [58, 59].
Failure to efficiently remove AcCHO exposes mitochon-
dria to protein, lipid, and DNA adduct formation such as
MDA, 4-NHE, and mixed MAA adducts [15]. Moreover, 4-
HNE, a lipid peroxidation derivative, can directly inhibit
ALDH2, thus promoting AcCHO accumulation in the mito-
chondrion in a endangering loop [60].
Consistently, the inactivating polymorphism ALDH2∗2,
common in East Asia, confers reduced alcohol tolerance and
is associated with increased risk of gastrointestinal cancer.
Very recently, by the use of a knock-in mice harboring the
ALDH2 (E487K) mutation, Jin and colleagues recapitulated
the ALDH2∗2 human phenotype including intolerance to
acute or chronic alcohol administration, impaired clearance
of AcCHO, increased DNA damage, and susceptibility to
cancer development [61].
Many of the abovementioned findings also apply to
the mitochondria of NASH patients, which have altered
morphology [62, 63], reduced or mutated mDNA content
[57], reduced oxidative phosphorylation [64], and increased
ROS production.
However, the molecular mechanisms initiating the mito-
chondrial dysfunction in NASH are different and originate
by an overwhelming induction of mitochondrial 𝛽-oxidation
rather than its inhibition as inASH.This is consistent with the
increased expression of UCP-2 observed in the mitochondria
of several obesity and NASH animal models and in the
expansion of peroxisomal 𝛽-oxidation found in humans.The
increased electron flux through the ETC produces oxidative
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stress, which is strongly associated with the severity of NASH
(Figure 2).
Depletion of mGSH occurs in NASH animal models,
similar to ASH [65], and in NASH patients that have reduced
levels of GSH, SOD, and catalase and increased protein
oxidation, a hallmark of increased oxidative stress [66]. In
principle, targeting oxidative stress is potential therapeutic
option for oxidative liver diseases [67]. Of notice, mGSH
depletion can affect also the outcome of potential therapeutic
antioxidant treatments, such as the use of SOD mimetics
in steatohepatitis. Indeed, the use of SOD2 mimetics in a
context of mGSH depletion results in increased H
2
O
2
levels
and increases liver injury in animal models of steatohepatitis,
highlighting the importance of a combinatory strategy in the
targeting of oxidative stress mechanisms [68].
3. Endoplasmic Reticulum
Endoplasmic reticulum (ER) is a master intracellular organ-
elle responsible for protein synthesis, folding, modification,
and trafficking. In addition, the ER plays a crucial role in
calcium homeostasis and in regulating the biosynthesis of
steroids, lipids, and carbohydrates [69].
During the folding process, a protein may be oxidized
to form disulfide bonds, isomerized to allow polypeptide
rearrangement or reduced to allow unfolding and subsequent
degradation [70].
The ER lumen has a high ratio of oxidized to reduced
glutathione (GSSG/GSH) (145), which creates an oxidizing
environment that promotes disulfide bond formation. The
electron transport required for this process is driven by
a protein pathway that involves two ER-located enzymes:
protein disulphide isomerase (PDI) and ER oxidoreductin 1
(ERO1) [71]. PDI directly accepts electrons, leading to the
oxidation of cysteine residues and the formation of disul-
phide bonds. In turn, ERO1 oxidizes PDI through a flavin-
dependent reaction and transfers electrons to molecular
oxygen as final acceptor. The use of molecular oxygen as the
terminal electron recipient leads to the production of ROS,
mainly hydrogen peroxide, contributing to cellular oxidative
stress [72].
It has been estimated that about 25%of theROS generated
in a cell derive from ER disulfide bond formation during
oxidative protein folding, thus making ER the major site of
ROS production [73] (Figure 1).
Furthermore, additional oxidative stress can result from
the depletion of reduced glutathione that is consumed during
the reduction of unstable and improperly formed disulphide
bonds [74].Therefore, an increase in the protein-folding load
in the ER can lead to the accumulation of ROS [75]. Cells have
evolved several strategies to oppose the ER accumulation
of unfolded and misfolded proteins, which are collectively
referred to as the UPR (unfolded protein response).
Under normal physiological conditions, the unfolded or
misfolded proteins are directed to degradative pathways to
restore the ER homeostasis; however, if the unfolded protein
production overwhelm the ER buffering capacity, the UPR
can activate a cascade of intracellular events resulting in
cell death [76, 77]. The UPR is of major importance in
hepatocytes, which are rich in ER content and responsible for
the synthesis of proteins, cholesterol, bile acids, and phospho-
lipids [78]. And it is characterized by the activation of three
distinct signal transduction pathways: the inositol requiring
1 (IRE1) pathway, the protein kinase RNA-like ER kinase
(PERK) pathway, and the activating transcription factor 6
(ATF6) pathway. Under nonstressed condition, these three
proteins are kept inactive by binding to a chaperone protein,
BiP/GRP78, which is the master regulator of the UPR. Under
stressed condition (due to, for example, accumulation of
misfolded or unfolded proteins, depletion of ER calcium
content, or increase of free cholesterol in the ER lumen)
BiP/GRP78 dissociates from the UPR transducers resulting
in activation of their respective signaling pathways.
Briefly, the activated IRE1𝛼 removes a 26-bp intron from
the XBP1 mRNA, resulting in the production of a spliced
XBP1 protein (XBP1s). XBP1s is a transcription factor that
regulates the expression of several genes involved in UPR
and ER-assisted degradation (ERAD) to help restore ER
homeostasis [79].The IRE1𝛼/Xbp1 pathway is also critical for
hepatic lipid homeostasis, since it activates the transcription
of master adipogenic regulators such as PPAR𝛾 and C/EBPs
[80]. In addition, IRE1𝛼 induces the activation of stress
kinases, JNK and p38 MAPK, that promote apoptosis [81].
The PERK pathway activates an antioxidant program
focused on ATF4 and nuclear factor-erythroid-derived 2-
(NF-E2-) related factor 2 (NRF2) [82, 83]. NRF2 is a key
player in antioxidant response. After PERK-mediated phos-
phorylation, NRF2 translocates to the nucleus and acti-
vates the transcription of a set of antioxidant and oxidant-
detoxifying enzymes, including NAD(P)H-quinone oxidore-
ductase (NQ01), heme oxygenase 1 (HO1), and glutathione
S-transferase (GST) [84, 85]. In addition, NRF2 and ATF4
induce the transcription of genes whose products are
involved in the maintenance of glutathione cellular level,
the main redox buffer in the cell [82, 83, 86, 87]. The
overall antioxidant effect of the PERK pathway is supported
by the finding that a potent ER-stress-inducing chemical,
tunicamycin, induces only weak accumulation of ROS in
wild-type cells, whereas this treatment induces a toxic accu-
mulation of ROS in cells that lack PERK [75].
Dissociation of BiP/GRP78 from ATF6𝛼 leads to its
translocation to the Golgi, where this protein is processed
into its active form [88]. The activated ATF6 translocates to
the nucleus and functions as a transcription factor, promoting
the expression of downstream target genes involved in ER
stress including XBP1, GADD153 (also known as CHOP, a
proapoptotic transcription factor that plays a critical role in
ER stress-mediated apoptosis), and ER chaperones [89, 90].
ATF6𝛼 is also a regulator of gluconeogenesis [91].
All together, these three pathways mitigate the ER stress
by reducing global protein synthesis, increasing misfolded or
unfolded protein degradation, and, simultaneously, increas-
ing the specific expression of proteins that help maintaining
the protein folding process in the ER lumen as well as ER
integrity [92–94].
Under pathological and/or stressful conditions, in which
the demand of protein synthesis, folding, and/or repair is
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increased, the UPR efficiency decreases, resulting in the
accumulation of unfolded protein andmisfolded proteins and
ER damage [93, 95–98].
Moreover, an overactivation of the UPR leads to a
sustained activity of ERO1 as well as induction of ERO1𝛽
expression [99], resulting in an increased H
2
O
2
production
[100] that is found in several liver diseases such as NASH,
ASH, and viral infection (Figure 2).
As a first-line response duringUPR activation, ER-related
PERK pathway attenuates general mRNA translation and
activates the Nrf2 transcription factor [71, 83, 92, 101, 102]
that translocates to the nucleus and activates antioxidant
responsive element-dependent gene expression [71, 75, 92, 93,
101]. However, in NASH, the UPR-induced Nrf2-mediated
response is downregulated [75]. Impaired Nrf2 activity is
associatedwithmitochondrial depolarization/dysfunction, as
well as increased hepatic free fatty acid levels, fatty liver,
and NASH development [102–104]. Moreover, NASH-related
accumulation of misfolded proteins, and related unmiti-
gated ER stress, also induces increased ROS production
and macromolecules oxidation in the ER lumen through
PDI, leading to intracellular depletion of reduced glutathione
[71, 72, 105]. Indeed, when oxidized, PDI with ERO1 acts
in the oxidative folding of proteins by allowing proper
disulfide bond formation. When reduced, PDI breaks and
rearranges disulfides in the nascent proteins until the reduced
glutathione pool is depleted [71, 73]. Furthermore, both ER
stress and oxidative damage prompt calcium leak from the
ER, leading tomitochondrial calciumaccumulation,which in
turn promotes exacerbated mitochondrial ROS production,
further amplifying ER stress [72, 104, 106] (Figure 2). It
has been recently suggested that elevated levels of palmitic
acid would compromise the ER ability to maintain calcium
stores, resulting in the stimulation ofmitochondrial oxidative
metabolism, ROS production, and, ultimately, cellular dys-
function [75]. Therefore, it appears that ER stress may occur
earlier than the onset of mitochondrial dysfunction, ROS
accumulation, and apoptosis [107, 108]. Moreover, SREBP-1,
themaster regulator of triglycerides and cholesterol synthesis,
is kept inactive at the ER by interaction with insulin induced
gene proteins (INSIGs). During ER stress, proteolytic degra-
dation of Insig-1 releases SREBP [96], which is subsequently
processed in theGolgi and finally directed to the nuclei where
it activates the transcription of the lipogenic program. In
turn, excess fatty acids and cholesterol promote ER stress;
thus, the reinforced cycle of ER stress, oxidative stress, and
lipogenesis-induced lipotoxicity fuels the pathogenesis of
NASH [78].
Alcoholic liver disease (ALD) is certainly related to an
excessive production of ROS from ethanol metabolism and
the consequent oxidative stress within the hepatocytes [109,
110]. Twometabolic pathways are involved in the degradation
of ethanol. First, ethanol is oxidized into acetaldehyde by
alcohol dehydrogenase (ADH), followed by production of
acetate by means of acetaldehyde dehydrogenase (ALDH).
Acetaldehyde mediates most of the toxic effect of alcohol
[15, 111, 112]. The second pathway of ethanol degradation,
which is largely inducible, operates through the microso-
mal ethanol-oxidizing system (MEOS) cytochrome P450.
CYP2E1, the main cytochrome P450 isoform induced by
ethanol consumption, is located at the membrane of ER
[113–116], making it the master mechanism of ER ethanol-
induced ROS production. Ethanol oxidation by CYP2E1
generates O
2
∙− and H
2
O
2
promoting membrane lipoper-
oxidation. Moreover, ethanol administration and ROS pro-
duction increase free iron, which catalyzes the production
of strong oxidants, such as hydroxyl radical (OH∙), ferrous
oxide (FeO), and hydroxyethyl radical (CH
3
CHOH). This
damaging mechanism is also common to lysosomes and
mitochondria (Figure 2).
The UPR overactivation and ROS production occur also
in Hepatitis C and B, but the process that induces these
responses is different from other liver diseases.
Hepatitis C virus (HCV) replication in infected host
cells is dependent on several viral proteins that are folded
in the ER and synthesized in ribonucleoprotein complexes
in association with the ER [117]. HCV replication has been
shown to cause ER stress and its gene products such as Core,
E2, NS5A, and NS4B have also been demonstrated to induce
UPR and ROS production [118, 119].
The protein aggregates that are formed in the viral
replication induce all three different pathways of UPR which
sustain viral replication alleviating ER stress [118, 119]. ROS
production during HCV infection also occurs due to altered
intracellular Ca+2 homeostasis. For example, Core viral
protein perturbs the intracellular calcium both by inducing
ER Ca2+ release and by stimulating the Ca2+ uniporter in
mitochondria, increasing ROS production in mitochondria
and opening of the mPTP [120]. Similarly, NS5A perturbs
Ca2+ signaling and elevates ROS production inmitochondria
leading to activation of transcription factors such as NF-𝜅B
and STAT that are involved inHCV-mediated hepatocarcino-
genesis [121]. NF-𝜅B activation is also stimulated by NS4B, a
mechanism requiring Ca2+-induced ROS production [122].
Similar mechanisms of UPR activation and ROS produc-
tion also occur in HBV infection [123] (Figure 2).
4. Lysosomes
Autophagy is a fundamental mechanism of cell adaptation
to stress, allowing removal of damaged molecules and cel-
lular components by degradation in the lysosomal compart-
ment, which is of particular importance for the removal of
nonfunctional mitochondria (mitophagy) (Figure 1). Alter-
ations of the autophagic pathway play a major role in the
onset and perpetuation of several chronic diseases, includ-
ing neurodegenerative and metabolic disorders as well as
cancer chemoresistance. Most of the processes associated
with RONS production also stimulate autophagy [124]. For
instance, starvation, through inhibition of mTOR pathway,
stimulates autophagy and increases mitochondrial ROS pro-
duction. H
2
O
2
oxidizes a redox-sensitive thiol of Atg4, which
then promotes LC3-I conversion to LC3-II and maturation
of the autophagosome [125]. Consistently, autophagy is stim-
ulated in vivo by mitochondrial superoxide production, as
seen by experimental downregulation of MnSOD, which
increases O
2
∙− and reduces H
2
O
2
[126]. However, it is not
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clear whether O
2
∙− directly stimulates autophagy or more
likely induces lipid peroxidation and mitochondrial dam-
age which in turn activate autophagy. This second line of
thought is supported by the observation that, in nutrient-
deprived hepatocytes, mitochondrial membrane depolariza-
tion precedes the formation of the autophagosome [127] and
defective mitophagy results in accumulation of dysfunctional
mitochondria, increases oxidative stress, and promotes tissue
liver damage and cancer [128]. Chronic ethanol feeding is
associated with decreased intralysosomal hydrolases content
and reduced proteasomal activity due to impaired cathepsin L
trafficking in the lysosome [129, 130]. Oxidative stress can also
harm lysosomal membranes resulting in elevated cytosolic
levels of cathepsin B due to lysosomal leakage [131].
The effect of ethanol metabolism on autophagy is quite
debated, and controversial results have been reported [132].
Using LC3-GFP transgenic mice, two groups described that
binge- [133], acute- or chronic-ethanol administration [134]
promoted autophagosome formation in vivo. The increase
in autophagosome formation was paralleled by inhibition of
mTORC1 signaling pathway [133].
In contrast, using a CYP2E1 knock-out or knock-in mice
and parallel in vitro model, Wu and colleagues showed that
binge ethanol administration reduced macroautophagy in
CYP2E1 KI mice and cells but not in KO mice [135]. Despite
the different autophagy status, which could be due to the use
of different transgenic models and different binge drinking
protocols, inhibition of autophagy enhanced ethanol toxicity
while pharmacological promotion of macroautophagy by
carbamazepine, as well as rapamycin, was shown to have
a therapeutic potential in animal models of acute ethanol-
induced toxicity [133] as well as ASH [135] and NASH [136].
Since ethanol is known to reduce the proteolytic activity
of lysosomes, it is possible that the degradative part of
autophagy, that is, the autophagolysosome formation, may
be impaired in chronic ethanol feeding despite increased
autophagosome formation, leading to defective removal of
damaged cellular components [137] (Figure 2).
This mechanism could be relevant also for the pathogen-
esis of NAFLD. In vitro experiments showed that autophagy
was increased in hepatoma cells exposed to FFA, mimicking
the “first hit” ofNASHpathogenesis. However, after a “second
hit” of H
2
O
2
or TNF𝛼 (oxidative damage and inflammation),
the autophagic flux diminished despite enhanced autophago-
some formation [138].
An important mechanism of ROS induced liver injury is
mediated by the release of “labile” iron (Fe2+) that occurs in
damaged lysosomes during ischemia/reperfusion [139].
Lysosomes are a major storage site of iron, which enters
the hepatocyte through transferrin mediated endocytosis,
subsequent endosome acidification, iron reduction, and
release from transferrin. Fe2+ is then released in the cytosol
or delivered tomitochondria in controlled amount (Figure 1).
Moreover, lysosomes can significantly increase their iron
content by reparative autophagic uptake of damaged mito-
chondria, peroxisomes, or cytosolic iron-loaded ferritin [29].
Labile iron is transported to mitochondria, where it catalyzes
the Fenton reaction with H
2
O
2
(see Section 1.2), producing
the deleterious hydroxyl (OH∙) and hydroxyperoxyl (OOH∙)
radicals which damagemitochondriamembranes and induce
the opening of the permeability transition pore, triggering
the RIRR response and eventually cell death (Figure 2). Fe2+
induced ROS formation can represent a potent mechanism
of damage amplification not only within the cellular com-
partments but also at the cell and organ level. In fact, many
human diseases, especially liver diseases, are associated with
increased serum ferritin levels that arise due to hepatocyte
death. Increased ferritin uptake in hepatocytes is associated
with abnormal endosome clustering and induces lysosomal
membrane permeability and promotes lipid peroxidation,
depletion of GSH, and reduction of GSH/GSSG ratio. Ferritin
accumulation triggersmacroautophagywhich is abolished by
Fe chelation, confirming the mechanistic role of Fe-induced
ROS formation in the onset of ferritin toxicity. Also in
this model, pharmacological inhibition of macroautophagy
strongly enhanced ferritin toxicity, further substantiating the
concept that induction of autophagy is a generalized defense
mechanism against ROS-mediated cellular damage [140].
5. Peroxisomes
Peroxisomes are ubiquitous organelles involved in catabolic
oxidative reactions, xenobiotic detoxification, and bile salt
synthesis. In mammals, peroxisomes carry on the 𝛼-oxida-
tion of very-long chain fatty acids that cannot directly enter
the mitochondria for 𝛽-oxidation[141].
Several peroxisomal oxidases produce ROS, primarily
H
2
O
2
, but also ∙NO, since iNOS was detected in peroxisomes
of hepatocytes [142]. Peroxisomes are not only a source of
ROS but also a powerful ROS disposal compartment, thanks
to a large array of antioxidant enzymes, mainly catalase, but
also GPx, Mn-SOD, and CuZn-SOD, and peroxyredoxin-1
and peroxyredoxin-5 [143] (Figure 1).
Peroxisomes are highly dynamic structures that undergo
enlargement, elongation, and increase in number in response
to several xenobiotic or physiologic stimuli.
Peroxisomes can support mitochondria in the 𝛽-oxida-
tion of fatty acids [144], a process mediated by the activation
of the nuclear receptor PPAR𝛼 [145]. Accordingly, peroxi-
somes are elevated in several mice models of NAFLD [146]
and proliferation and enlargement of peroxisomes are also
described in patients with fatty liver [147] (Figure 2).
Activation of PPAR𝛼 and subsequent induction of perox-
isomal 𝛽-oxidation is a potent inducer of H
2
O
2
production
which is not paralleled by an equal increase in antioxidant
enzymes, mainly catalase, leading to oxidative stress and
substantially contributing to the hepatocarcinogenic effects
of PPAR𝛼 activators observed in mice, but not in humans
[148].
Disruption of the peroxisomal structure and function in
the hepatocyte, as in the PDX5 knock-out mice, resulted
in structural alteration and reduced functionality of mito-
chondria, increased proliferation of ER and lysosomes, and
accumulation of lipid droplets. Surprisingly, no sign of signif-
icant oxidative stress was found, although metabolic rear-
rangement toward a more glycolytic setting was observed
[149].
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6. Plasma Membrane
At the plasma membrane interface, key signal transduction
events originate following the ligand-receptor interaction.
Signal transduction is biologically encoded by phosphory-
lation of key Tyr or Ser/Thr residues that induce confor-
mational and functional changes in transducing proteins.
The coordinated activities of protein kinases and protein
phosphatases ensure the substrate, temporal, and spatial con-
finement required to obtain specificity for signal transduction
events. Signal transduction occurs not only by means of the
well-known “phosphorylation code,” but also by regulation
of redox-sensitive Cys residues in signaling proteins. Such
“redox-code” [21] adds a level of complexity and flexibility to
signaling circuitry.
The best characterized redox regulation of kinase sig-
naling, and likely the most relevant to the hepatocyte, is
the insulin pathway. Insulin binding to its receptor acti-
vates intrinsic kinase activity and initiates a phosphorylation
cascade through the PI3K/AKT/mTOR pathway. In parallel,
insulin promotes the deactivation of protein phosphatases
(PTEN, PP2A, and SH2P), a mechanism requiring localized
H
2
O
2
burst at the plasmamembrane generated by extracellu-
lar NOX [150–153] (Figure 1).
Adiponectin, which potentiates insulin action, activates
5-LOX H
2
O
2
bursts and deactivates PTP1B [154].
Exogenous H
2
O
2
administration can therefore modulate
insulin signaling through inhibition of Protein Tyrosine
Phosphatases (PTP), as recently demonstrated by Iwakami
et al. [155].
The ROS-mediated inactivation of PTP is a general
physiological mechanism necessary for efficient signal trans-
duction of several, if not all, MAPK family members [2],
including p38 [9, 156], JNK [157], and ERK1/2 [158] (Figure 1).
Removal of signaling H
2
O
2
and reduction of oxidized
Cys in PTP are ensured by cytoplasmic antioxidants, such
as GSH, thioredoxin 1 [159] and peroxiredoxin-2 [152], thus
terminating the signaling activity.
Although H
2
O
2
is required for normal signal trans-
duction, excess oxidative stress can activate stress-sensitive
Ser/Thr kinase such as JNK, ERK1 and IKKb (inhibitor of NF-
𝜅B), and p70S6k, all of which are client of the redox-regulated
protein phosphatase PP2A. Stress sensitive kinases take part
in insulin resistance by inhibitory phosphorylation of IRS-1
[160] (Figure 2).
Clearly, redox signaling is highly intertwined with phos-
phorylation signaling, and a high level of spatial and temporal
confinement must be fulfilled to ensure the proper biological
response.
Very recently, Hua and colleagues uncovered the coor-
dinated redox mechanisms initiating and terminating hepa-
tocyte proliferation during liver ontogenesis or regeneration
after partial hepatectomy [161]. They found that sustained
elevated H
2
O
2
levels are required for the activation of ERK
signaling and trigger a shift from quiescence to prolifer-
ation, while sustained decreased H
2
O
2
levels activate p38
signaling and trigger a shift from proliferation to quiescence.
Pharmacological lowering of H
2
O
2
levels reduces the extent
of fetal hepatocyte proliferation and delays the onset of
liver regeneration. Chemical augmentation of H
2
O
2
levels
in adult hepatocytes triggers proliferation and delays the
termination of liver regeneration. Although the authors did
not map the precise cellular location of H
2
O
2
production,
the mechanism triggering the H
2
O
2
-induced hepatocyte
proliferation during embryogenesis and liver regeneration
involves early induction of NADPH Oxidase 4 (NOX4) and
the adaptor protein p66shc [161], which is known to be
necessary for NOX assembly at the plasma membrane [162].
Interestingly, NOX4 recruitment at the plasma membrane
and localized H
2
O
2
production are also required for IGF-
I signal transduction to Src, a mechanism mediated by
the scaffold protein SHPS-1 [163], suggesting that NOX4
assembly at the plasma membrane could promote specific
signal transduction by redox regulation of different client
effectors.
In hepatocytes, membrane fluidity and lipid-raft cluster-
ing have been described to mediate ethanol-induced oxida-
tive stress. ROS produced by ethanol metabolism increase
plasma membrane fluidity and determine an increase in low-
molecular weight iron, triggering massive ROS production
and membrane peroxidation [164]. These event are associ-
ated with lipid-raft clustering, intraraft disulfide-bond and
peroxidation, phospholipase C recruitment inside the lipid-
raft, and activation of a signaling pathway that modulate
iron content in the lysosomal compartment [165] (Figure 2).
Consistently, reducing lipid-raft clustering and oxidation by
DHA administration [166] or increasing plasma membrane
fluidity by benzo(a)pyrene administration [167], respectively,
alleviated or worsened the ethanol toxicity mediated by
increased lysosomal iron leakage. Since membrane lipid rafts
are required for peroxisome biogenesis [168], it would be
interesting to assess the effect of ethanol-induced lipid-raft
clustering on peroxisome structure and function.
7. Concluding Remarks
Redox homeostasis in the cell is achieved by accurate com-
partmentalization of prooxidants and RONS buffering sys-
tems. Each cellular compartment differs in the overall redox
state as well as in the concentration and oxidative steady-state
of its antioxidant pairs. Lysosomes and ER are relatively more
oxidizing than cytoplasm, while more reducing conditions
are found in the nuclei and mitochondria. Each of these
compartments is actively maintained in a nonequilibrium
redox state to fulfill specific tasks. At the same time, cellular
organelles are highly interconnected by a complex network
of physical connections, signaling pathways, intracellular
trafficking routes, and metabolic activities.
Oxidative stress can arise by different mechanism in any
cellular compartment and spread to other cellular organelles
through any of the physical or functional connections.
For instance, mild alterations of plasma membrane per-
meability induced by ethanol metabolism promote clus-
tering of lipid raft and increase ferritin uptake that pro-
mote membrane lipid peroxidation and free iron leakage
from the lysosome. Free iron is eventually transported to
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the mitochondria where it triggers a burst of oxidative stress
and opening of the mPTP, propagating the oxidative damage
through the RIRR mechanism (Figure 2).
Perturbation of the network of physical and functional
connections between cellular organelles is not only a conse-
quence of pathological oxidative stress but can be indeed the
primary causal mechanism of oxidative stress and morbidity.
In a recent paper, Arruda and colleagues, by using an elegant
in vivo strategy, demonstrated that artificially increasing the
physical interaction between mitochondria and ER (MAMs:
mitochondrial-associated ER membranes) in the liver led to
altered calcium load in themitochondria, increased oxidative
stress, and metabolic alterations, promoting obesity and
metabolic dysfunction [169]. Rearrangement of ER around
mitochondria seems to be an early event after HFD treatment
and likely reflects a transient adaptation of this physiologi-
cally highly dynamic process (Figure 2).
The recent development of genetically encoded ROS
sensor paved the way for a new era of exploration in the redox
cell biology, allowing real-time detection and measure of the
redox dynamics in living cells. These technological advances
are contributing to unravel the complex spatial and temporal
dynamics of H
2
O
2
bursts that, acting as switches, can activate
or deactivate signaling components, thus interconnecting the
redox-based and kinase-based signaling pathways.
Aswe deepen the understanding of the redox homeostasis
in the different cellular compartment, the concept of “oxida-
tive stress” evolves and alterations of redox mechanisms are
increasingly being recognized in human diseases, revealing
the potential for new therapeutic opportunities.
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